August 11, 2015

geniVida has been shown in a double blind placebo controlled randomized clinical study to help reduce both the number and duration of hot flashes in healthy menopausal women, Doctor's Best noted. 

April 14, 2015

ANI Pharmaceuticals banking on strong growth in generics. 

December 17, 2014

PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.

December 9, 2014

BioPharmX on Tuesday announced the availability of Violet iodine, a new once-daily supplement for relief of premenstrual breast discomfort.

August 28, 2014

The steep decline in the use of hormone therapy has spawned a prevalent but preventable side effect: Millions of women suffering in silence with hot flashes, according to a study by a Yale School of Medicine researcher and colleagues.

August 20, 2014

The successful introduction of Estroven Weight Management is bringing new users to the menopause supplement category, said April Mills, marketing director of i-Health, a division of DSM.

August 20, 2014

Meda Consumer Healthcare’s MidNite for Menopause last year was honored as one of Parade magazine’s top new products of the year.

July 30, 2014

Helios Corp. on Wednesday announced the introduction of a botanical supplement for the relief of menopause symptoms, EstroG-100, which is found in Advanced Menopause Relief from CVS, Menopause Relief from Walgreens, Best EstroG-100 from Doctor's Best, Herbal Pause from NOW Foods and EstroG-100 from Swanson Nutrition.

July 11, 2014

Lake Consumer Products, a subsidiary of Wisconsin Pharmacal Co., on Thursday acquired the exclusive North American rights to an over-the-counter product that addresses many of the key symptoms associated with premenstrual syndrome.

May 30, 2014

Mission Pharmacal on Thursday announced that it has begun the promotion of Elestrin (estradiol gel) 0.06% in the United States through an agreement with Meda AB. The drug is a used as a topical hormone replacement gel to help treat hot flashes caused by menopause.

May 15, 2014

i-Health has been carving out new niches with its feminine pain reliever brand Estroven, which as a brand family generated more than $37.2 million in sales across total U.S. multi-outlets for the 52 weeks ended Dec. 29, 2013, according to IRI.

March 12, 2014

A new study suggests that calcium and vitamin D supplements after menopause can improve women's cholesterol profiles, and much of that effect is tied to raising vitamin D levels.

March 4, 2014

Church & Dwight on Tuesday announced that the Food and Drug Administration has cleared the First Response Gold Digital Pregnancy Test to determine if a woman is pregnant up to six days before her missed period and with more than 99% accuracy from the day of her expected period.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

August 28, 2013

Swiss Precision Diagnostics recently launched its Clearblue Advanced Pregnancy Test with Weeks Estimator — the first and only pregnancy test that also provides an estimate of time since ovulation for women testing pregnant — into the U.S. marketplace.

July 2, 2013

i-Health unveiled its Estroven Weight Management, a supplement specifically formulated to address the physical changes of menopause plus deliver on a core benefit of helping peri/menopausal women manage their weight as they go through this stage of life.

May 6, 2013

Swiss Precision Diagnostics unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here.

May 3, 2013

Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

April 9, 2013

Procter & Gamble launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company.

April 1, 2013

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

February 26, 2013

The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.

February 25, 2013

In View, the Discovery Channel program of which Larry King is host, will include a feature about DivaCup, a reusable menstrual cup.

February 19, 2013

Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.

January 8, 2013

The Electronic Retailing Self-Regulation Program recommended that Casper Labs modify or discontinue certain claims for Calmestra, a dietary supplement marketed as providing relief for symptoms of menopause, including claims that the product has been “clinically proven” to address symptoms of menopause.